Rheumatoid arthritis markers

摘要

The invention provides methods and materials for evaluating arthritis conditions. Specifically, the invention provides methods and materials for determining the severity of an arthritis condition in a mammal that involve determining whether or not a sample from that mammal contains an elevated level of a CD21L polypeptide, a lymphotoxin-beta polypeptide, or a chemoattractant polypeptide. The invention also provides methods and materials for assisting medical or research professionals in determining the severity of an arthritis condition in a mammal. In addition, the invention provides methods and materials related to kits that can be used to determine the severity of an arthritis condition.